Brain-Behavior Interactions in Tic Suppression
The purpose of this study is to examine how the brain and environment interact to influence children's ability to suppress tics using a medical technology called Transcranial Magnetic Stimulation (TMS).
|Condition or Disease||Intervention/Treatment||Phase|
Objectives: This study will recruit youth with chronic tics. Chronic tics are the most common movement disorder in children. The goal of the study is to learn how the brain and environment influence children's ability to suppress tics. Specifically, we want to learn how tics are influenced by a certain part of the brain called the supplementary motor area (SMA). This part of the brain is thought to be more active in people with tics. This will be the first study to look at the relationship between SMA, tic suppression, and urges to tic.
Research Procedures: The study will take place over the course of three days within a week (about 5 hours total). The study will examine the relationship between the SMA and tic suppression using a non-invasive medical technology called Transcranial Magnetic Stimulation (TMS). Participants will have a diagnostic interview, MRI brain scan (used to find the location of the SMA), and TMS. Participants will be asked to try to suppress tics before and after TMS. The information that will be collected from participation includes information about tic symptoms, emotional and behavioral functioning, and brain activity (from MRI brain images and TMS results).
Arms and Interventions
Participants in this group will receive one, 30 minute session of inactive ("sham") TMS.
Other: Sham TMS
There will be one, 30-minute TMS session. Participants randomly assigned to this group will receive inactive ("sham") TMS. Tics and urges will be monitored immediately before and after TMS.
Participants in this group will receive one, 30 minute session of 1hz TMS.
Other: Active TMS
There will be one, 30-minute TMS session. Participants randomly assigned to this group will receive 1hz "active" TMS. Tics and urges will be monitored immediately before and after TMS.
Primary Outcome Measures
- Tic frequency [Day 3]
Tics will be observed and counted
Secondary Outcome Measures
- Urge to tic [Day 3]
The participant will be asked to give subjective ratings of premonitory urge intensity
Presence of motor and/or vocal tics for at least one year
Participants with medical conditions that are contraindicated for TMS (history of any known intracranial pathology, epilepsy or seizures, traumatic brain injury, brain tumor, stroke, implanted medical devices, current pregnancy or girls of childbearing age not using effective contraception, or any other serious medical conditions
Previous diagnosis of psychosis, autism spectrum disorder, mental retardation, or cognitive disability
Inability to undergo MRI
Substance abuse or dependence within the past year
History of ≥3 sessions of Habit Reversal Therapy or other treatment primarily comprised of tic suppression strategies
Current suicidal intent
Current neuroleptic medications, as these medications are known to lower seizure threshold
Contacts and Locations
|1||University of Minnesota||Minneapolis||Minnesota||United States||55455|
Sponsors and Collaborators
- University of Minnesota
- Principal Investigator: Christine Conelea, PhD, University of Minnesota
Study Documents (Full-Text)None provided.